BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30300333)

  • 1. The potential effect of human chorionic gonadotropin on vasoproliferative disorders of the immature retina.
    Movsas TZ; Muthusamy A
    Neuroreport; 2018 Dec; 29(18):1525-1529. PubMed ID: 30300333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of Signaling by the Luteinizing Hormone Receptor Reduces Ocular VEGF and Retinal Vascularization during Mouse Eye Development.
    Movsas TZ; Sigler R; Muthusamy A
    Curr Eye Res; 2018 Oct; 43(10):1286-1289. PubMed ID: 29966451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
    Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
    Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity.
    Hackett SF; Seidel C; Abraham S; Chadha R; Fortmann SD; Campochiaro PA; Cooke JP
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1296-1303. PubMed ID: 28241318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
    Shih SC; Ju M; Liu N; Smith LE
    J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice.
    Xu Y; Lu X; Hu Y; Yang B; Tsui CK; Yu S; Lu L; Liang X
    J Pineal Res; 2018 May; 64(4):e12473. PubMed ID: 29411894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice.
    Hirahara S; Nozaki M; Ohbayashi M; Hasegawa N; Ozone D; Ogura Y
    Ophthalmic Res; 2017; 58(1):56-66. PubMed ID: 28376500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
    Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
    Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
    Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
    Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
    Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
    Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TLR4-MAP4K4 signaling pathway in models of oxygen-induced retinopathy.
    Chen W; Zhang J; Zhang P; Hu F; Jiang T; Gu J; Chang Q
    FASEB J; 2019 Mar; 33(3):3451-3464. PubMed ID: 30475644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
    Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy.
    Donahue ML; Phelps DL; Watkins RH; LoMonaco MB; Horowitz S
    Curr Eye Res; 1996 Feb; 15(2):175-84. PubMed ID: 8670726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E2 and E3, but Not E4, Promote Retinal Pathologic Neovascularization.
    Masuda T; Shimazawa M; Hashimoto Y; Kojima A; Nakamura S; Suemori S; Mochizuki K; Kawakami H; Kawase K; Hara H
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1208-1217. PubMed ID: 28241308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles.
    Christenson LK; Stouffer RL
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2135-42. PubMed ID: 9215284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
    Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
    Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
    Wang J; Lin J; Kaiser U; Wohlfart P; Hammes HP
    Acta Diabetol; 2017 Apr; 54(4):383-392. PubMed ID: 28070752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization.
    Hu J; Song X; He YQ; Freeman C; Parish CR; Yuan L; Yu H; Tang S
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6810-7. PubMed ID: 22956610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.